American Industrial Partners Completes Acquisition of Avanos Medical, Inc.

Rhea-AI Summary

Avanos Medical (NYSE: AVNS) has been acquired by affiliates of investment funds advised by American Industrial Partners (AIP) in a transaction valued at approximately $1.272 billion. Under the merger agreement, Avanos stockholders will receive $25.00 in cash per share of common stock they own.

Following the closing, Avanos common stock will cease trading on the New York Stock Exchange and the company will become privately held. According to AIP and Avanos, the partnership is intended to support Avanos’ growth and innovation roadmap in the medical technology sector. Legal, financing and financial advisors to both parties included Sidley Austin, Ropes & Gray, Baker Botts, J.P. Morgan Securities, UBS Investment Bank and Alston & Bird.

Positive

• $1.272 billion all-cash acquisition value for Avanos
• Shareholders receive $25.00 cash for each AVNS share
• Transaction closing completed; cash consideration now deliverable to investors

Negative

• Avanos common stock to cease trading on NYSE, ending public market liquidity
• Company becomes private, eliminating future participation in Avanos as a public equity

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK and ALPHARETTA, Ga., July 27, 2026 /PRNewswire/ -- American Industrial Partners ("AIP"), an operationally-oriented industrials investor, today announced the closing of the acquisition of Avanos Medical, Inc. ("Avanos" or the "Company") by affiliates of investment funds advised by AIP in a transaction valued at approximately $1.272 billion.

Under the terms of the merger agreement, Avanos stockholders will receive $25.00 per share in cash for each share of common stock they own. With the completion of the transaction, the Company's common stock will cease trading on the New York Stock Exchange and Avanos will become a private company.

Joel Rotroff, Partner at AIP, said, "We are excited to partner with Avanos to deliver a compelling platform for continued growth in the medical technology sector. We are confident that by leveraging AIP's deep operational expertise and resources, Avanos will be in a strong position to build on its momentum and achieve long-term success."

"Avanos enters this next chapter with real momentum, and AIP is the right partner to help us build on it," stated Dave Pacitti, Avanos CEO. "AIP's operational depth means we can move faster on the innovation roadmap our teams have already put in motion and do it with the resources to match our ambition. I thank our employees for their continued dedication and commitment to providing solutions that enable patients to get back to what matters."

Advisors

Sidley Austin LLP served as legal counsel, Ropes & Gray LLP served as financing counsel and Baker Botts LLP served as regulatory counsel to AIP.

J.P. Morgan Securities LLC served as lead financial advisor and Alston & Bird, LLP served as legal counsel to Avanos. UBS Investment Bank also served as a financial advisor to Avanos.

About American Industrial Partners

American Industrial Partners is an operationally oriented industrials investor with approximately $17.8 billion in assets under management. AIP seeks to achieve differentiated returns by investing in quality engineered products businesses with strong management teams and working with those teams to implement transformative Operating Agendas to build long-term value. The AIP team has deep roots in the industrial economy and has actively invested across three economic cycles. AIP has completed over 145 platform and add-on acquisitions and invests in all forms of corporate divestitures, management buyouts, recapitalizations, and going-private transactions of established businesses with sales greater than $500 million. Current AIP portfolio companies generate aggregate annual revenues of approximately $32 billion and employ 74,000+ employees as of March 31, 2026. www.americanindustrial.com

About Avanos Medical, Inc.

Avanos Medical, Inc. is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to what matters. Headquartered in Alpharetta, Georgia, we are committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands globally and holds leading market positions in multiple categories across its portfolio. For more information, visit avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn and Facebook.

View original content to download multimedia:https://www.prnewswire.com/news-releases/american-industrial-partners-completes-acquisition-of-avanos-medical-inc-302835264.html

SOURCE Avanos Medical

FAQ

What did American Industrial Partners pay to acquire Avanos Medical (AVNS)?

American Industrial Partners completed the Avanos Medical acquisition in a transaction valued at about $1.272 billion. According to Avanos, affiliates of funds advised by AIP acquired the company, with existing stockholders receiving a fixed $25.00 in cash per common share.

How much cash per share do Avanos Medical (AVNS) stockholders receive in the AIP deal?

Avanos Medical stockholders receive $25.00 in cash per share under the merger agreement with American Industrial Partners. According to Avanos, this fixed cash payment applies to each outstanding share of common stock held at closing of the transaction.

What happens to Avanos Medical (AVNS) stock after the American Industrial Partners acquisition?

After the acquisition closing, Avanos common stock will cease trading on the New York Stock Exchange. According to Avanos, the company will become privately held, meaning its shares will no longer be available as a publicly traded security for investors.

Is Avanos Medical still a public company after the July 27, 2026 AIP transaction?

No. Following the July 27, 2026 closing, Avanos becomes a private company owned by AIP-advised funds. According to Avanos, its common stock will be delisted from the NYSE and existing investors are cashed out at $25.00 per share.

Who advised Avanos Medical (AVNS) and American Industrial Partners on the acquisition transaction?

Several legal and financial firms advised both sides on the Avanos–AIP deal. According to the companies, Sidley Austin, Ropes & Gray and Baker Botts advised AIP, while J.P. Morgan Securities, UBS Investment Bank and Alston & Bird advised Avanos on finance and legal matters.